The new Bachelor of Science in Pharmaceutical and Medical Sciences program is designed to help community college students enter health care fields. Classes will start in fall 2024.
Safety concerns related to the widely used painkiller diclofenac may be tied to a little-studied drug-metabolizing enzyme whose expression can vary widely from one individual to the next, according to new research.
Located in Spokane, the new clinic will help reduce the wait time for eastern Washington families seeking autism spectrum disorder evaluations for their children.
The program is designed for health care executives to sharpen their leadership skills and business competencies and for rising health care professionals to advance their careers.
People living in the U.S. must travel more than three times farther to access methadone treatment for opioid addiction than Canadians, a new WSU-led study indicates.
The college was evaluated on many standards including curricular delivery, quality of faculty and staff, and approach to practice and care by the Accreditation Council for Pharmacy Education.
Gitau will lead the campus’ student affairs office, including admissions, financial aid, support services, and student-centered programming for approximately 1,400 students in Spokane and Yakima.
Cannabidiol or CBD, a non-psychoactive component of cannabis, inhibits the metabolism of nicotine, new WSU-led research has found, meaning it could help tobacco users curb the urge for that next cigarette.
WSU scientists are helping to develop safer drug dosing standards for children and other populations that are underrepresented in clinical drug trials.